This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more highlights of prescribing information - Takeda

While the drug remains on the market in the U.S., the FDA prescribing information now includes warnings about the potential bladder cancer risk. 3. Warning Signs and Symptoms

In 2011, the FDA issued a safety communication warning about these risks. Around the same time, countries like France and Germany suspended or restricted the use of the drug.

Research has suggested that long-term use of Actos may be associated with a higher risk of developing bladder cancer.

While many historical claims have been settled, legal discussions continue regarding newer cases or different types of injuries. You can find more information on legal rights through resources like Top Class Actions or RK Attorneys . 5. What Should You Do?

In 2015, Takeda Pharmaceuticals agreed to a massive $2.37 billion settlement to resolve approximately 9,000 bladder cancer claims in the U.S..